Comparative Effectiveness of Treatments to Prevent Dental Caries

Sponsor
NYU College of Dentistry (Other)
Overall Status
Recruiting
CT.gov ID
NCT03448107
Collaborator
National Institute on Minority Health and Health Disparities (NIMHD) (NIH)
3,960
1
2
67.3
58.9

Study Details

Study Description

Brief Summary

Dental caries (tooth decay) is the most prevalent childhood disease in the world. Multiple interventions are available to treat and prevent caries. The aim of the proposed study is to compare the benefit of silver diamine fluoride (SDF) and fluoride varnish versus fluoride varnish and glass ionomer sealants. This study is a five-year, cluster randomized, pragmatic controlled trial conducted in public elementary schools in New Hampshire.

Condition or Disease Intervention/Treatment Phase
  • Device: Silver Diamine Fluoride
  • Device: Fluoride Varnishes
  • Device: Glass Ionomer
N/A

Detailed Description

Dental caries is the most prevalent childhood disease in the world and can lead to infection, pain, reduced quality of life, and negative educational outcomes. Multiple prevention agents are available to arrest and prevent dental caries, however little is known of the comparative effectiveness of combined treatments in pragmatic settings. The aim of the presented study is to compare the benefit of silver diamine fluoride and fluoride varnish versus fluoride varnish and glass ionomer therapeutic sealants in the arrest and prevention of dental caries.

This is a longitudinal, pragmatic, cluster randomized, single-blind, non-inferiority trial to be conducted in low-income children enrolled in public elementary schools in New Hampshire from 2017-2023. The primary objective is to assess the non-inferiority of alternative agents in the arrest and prevention of dental caries. Caries arrest will be evaluated after two years, and caries prevention will be assessed at the completion of the study. Data analysis will follow intent to treat, and statistical analyses will be conducted using a two-sided significance level of 0.05.

Notably, the standard of care for dental caries is office-based surgery, which presents multiple barriers to care including cost, fear, and geographic isolation. The simplicity and affordability of silver diamine fluoride may be a viable alternative for the arrest and prevention of dental caries in high-risk children.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
3960 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Two-arm, parallel, non-inferiority cluster randomized trialTwo-arm, parallel, non-inferiority cluster randomized trial
Masking:
Single (Outcomes Assessor)
Masking Description:
The investigators responsible for analyzing the data for primary outcomes will be masked.
Primary Purpose:
Prevention
Official Title:
Comparative Effectiveness of Treatments to Prevent Dental Caries Given to Rural Children in School-based Settings: Protocol for a Cluster Randomized Controlled Trial
Actual Study Start Date :
Sep 20, 2017
Anticipated Primary Completion Date :
Apr 30, 2023
Anticipated Study Completion Date :
Apr 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Simple Prevention

One drop (0.05 ml) of silver diamine fluoride (Advantage ArrestTM) solution at 38% concentration (2.24 F-ion mg/dose) will be dispensed per child. Posterior tooth surfaces to be treated will be dried, after which the SDF will be applied with a micro-brush to all asymptomatic carious lesions and to all pits and fissures on bicuspids and molar teeth for thirty seconds. Fluoride varnishes (5% NaF) will then be applied to all teeth. Dosage frequency will be twice-yearly.

Device: Silver Diamine Fluoride
Silver diamine fluoride (SDF)
Other Names:
  • Advantage Arrest
  • Device: Fluoride Varnishes
    Fluoride varnish (FV)

    Active Comparator: Complex Prevention

    Pits and fissures on all bicuspids and molar teeth will be sealed with glass ionomer sealants (GC Fuji IX). Glass ionomer sealants (interim therapeutic restorations) will also be placed on all frank asymptomatic carious lesions. Fluoride varnishes (5% NaF) will then be applied to all teeth. Dosage frequency will be twice-yearly.

    Device: Fluoride Varnishes
    Fluoride varnish (FV)

    Device: Glass Ionomer
    Glass Ionomer Sealants (GC Fuji IX)

    Outcome Measures

    Primary Outcome Measures

    1. Arrest of dental caries assessed based on a clinical oral examination [Two years]

      For any untreated dental caries on teeth at baseline treated with SDF/FV or Glass ionomer/FV to arrest (control) the infection, what is the proportion of treated (arrested) caries that stayed arrested

    2. Caries prevention [Five years]

      For teeth without carious lesions (sound teeth) treated with SDF/FV or Glass ionomer/FV, what proportion of teeth stayed sound

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    5 Years to 12 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Any primary school with a previously employed caries prevention program operating in rural areas, with official Title 1 status, and located in a health professional shortage area. Within participating schools, all children are eligible to participate in the study. Those with informed consent and assent will receive care.
    Exclusion Criteria:
    • Children without informed consent or those with consent but without assent.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 New York University College of Dentistry New York New York United States 10010

    Sponsors and Collaborators

    • NYU College of Dentistry
    • National Institute on Minority Health and Health Disparities (NIMHD)

    Investigators

    • Principal Investigator: Richard Niederman, DMD, NYU Langone Health
    • Principal Investigator: Ryan R Ruff, MPH, PhD, NYU Langone Health

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Richard Niederman, Professor, NYU College of Dentistry
    ClinicalTrials.gov Identifier:
    NCT03448107
    Other Study ID Numbers:
    • i17-01221
    • R01MD011526
    First Posted:
    Feb 27, 2018
    Last Update Posted:
    Oct 8, 2020
    Last Verified:
    Oct 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    Yes
    Product Manufactured in and Exported from the U.S.:
    No
    Keywords provided by Richard Niederman, Professor, NYU College of Dentistry
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 8, 2020